DENTSPLY SIRONA Inc. (XRAY)
Data as of , from SEC Form 4 filings.
See up to 3 months of XRAY. The 7-day demo opens the 1M and 3M ranges and puts XRAY on your watchlist.
Start 7-day demoLatest XRAY insider trades
Jonathan Jay Mazelsky - DirectorOpen-market purchase$101K
Clyde Hosein - DirectorOpen-market purchase$65K
About DENTSPLY SIRONA Inc. (XRAY)
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.
- CHARLOTTE, NC
- 14,000
- 1983
- XNAS
XRAY Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 3 | 131,537 | |
| Tax withholding / forfeiture | 1 | 802 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
XRAY insider transactions (Form 4)
37124 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jonathan Jay Mazelsky - Director | Grant or award | Phantom Stock (Directors' Deferred Compensation) DDC | 3,323 footnote F2 | $9.03 | $30K | |
| ||||||
| John C. Fortson - Officer | Grant or award | Common Stock | 24,014 footnote F1 | $0.00 | - | |
| John C. Fortson - Officer | Grant or award | Stock Option (Right to Buy) | 104,200 | $0.00 | - | |
| ||||||
 Andrea L. Frohning - Officer | Tax withholding / forfeiture | Common Stock | 802 footnote F1 | $12.12 | $10K | |
| ||||||
| Jonathan Jay Mazelsky - Director | Grant or award | Phantom Stock (Directors' Deferred Compensation) DDC | 2,842 footnote F2 | $10.56 | $30K | |
| ||||||
| Jonathan Jay Mazelsky - Director | Open-market purchase | Common Stock | 10,000 | $10.14 | $101K | |
| Clyde Hosein - Director | Open-market purchase | Common Stock | 6,500 | $9.99 | $65K | |
| Brian P. McKeon - Director | Open-market purchase | Common Stock | 10,000 | $10.12 | $101K | |
 Brian T. Gladden - Director | Open-market purchase | Common Stock | 9,985 | $10.02 footnote F1 | $100K | |
| ||||||
| Jonathan Jay Mazelsky - Director | Grant or award | Common Stock | 10,000 | $10.14 | $101K | |
| Betsy D. Holden - Director | Open-market purchase | Common Stock | 10,086 | $9.88 footnote F1 | $100K | |
| ||||||
| Michael J. Barber - Director | Open-market purchase | Common Stock | 15,175 | $9.89 footnote F1 | $150K | |
| ||||||
| Gregory T. Lucier - Director | Grant or award | Common Stock | 38,382 footnote F1 | $0.00 | - | |
| Gregory T. Lucier - Director | Gift | Common Stock | 38,382 footnote F2 | $0.00 | - | |
| Gregory T. Lucier - Director | Gift | Common Stock | 38,382 footnote F2 | $0.00 | - | |
| Gregory T. Lucier - Director | Grant or award | Stock Option (Right to Buy) | 10,900 | $0.00 | - | |
| Gregory T. Lucier - Director | Gift | Stock Option (Right to Buy) | 10,900 footnote F4 | $0.00 | - | |
| Gregory T. Lucier - Director | Gift | Stock Option (Right to Buy) | 10,900 footnote F4 | $0.00 | - | |
| ||||||
| Donald Zurbay - Director | Grant or award | Common Stock | 22,822 footnote F1 | $0.00 | - | |
| ||||||
 Janet S. Vergis - Director | Grant or award | Common Stock | 22,822 footnote F1 | $0.00 | - | |
| ||||||
| Leslie F. Varon - Director | Grant or award | Common Stock | 22,822 footnote F1 | $0.00 | - | |
| ||||||
| Brian P. McKeon - Director | Grant or award | Common Stock | 28,887 footnote F1 | $0.00 | - | |
| ||||||
| Jonathan Jay Mazelsky - Director | Grant or award | Common Stock | 22,822 footnote F1 | $0.00 | - | |
| ||||||
| Clyde Hosein - Director | Grant or award | Common Stock | 22,822 footnote F1 | $0.00 | - | |
| ||||||
| Betsy D. Holden - Director | Grant or award | Common Stock | 22,822 footnote F1 | $0.00 | - | |
| ||||||
| Brian T. Gladden - Director | Grant or award | Common Stock | 22,822 footnote F1 | $0.00 | - | |
| ||||||
| James D. Forbes - Director | Grant or award | Common Stock | 28,887 footnote F1 | $0.00 | - | |
| ||||||
| Michael J. Barber - Director | Grant or award | Common Stock | 22,822 footnote F1 | $0.00 | - | |
| ||||||
 Daniel T. Scavilla - Officer | Tax withholding / forfeiture | Common Stock | 4,095 footnote F1 | $10.21 | $42K | |
| ||||||
| Jonathan Jay Mazelsky - Director | Grant or award | Phantom Stock (Directors' Deferred Compensation) DDC | 2,645 footnote F2 | $11.34 | $30K | |
| ||||||
| Daniel T. Scavilla - Officer | Grant or award | Phantom Stock (Supplemental Executive Retirement Plan) SERP | 3,555 footnote F2 | $11.43 footnote F3 | $41K | |
| ||||||
 Aldo Mariano Roberto Denti - Officer | Grant or award | Phantom Stock (Supplemental Executive Retirement Plan) SERP | 829.4 footnote F2 | $11.43 footnote F3 | $9K | |
| ||||||
| Kevin Czerney - Officer | Grant or award | Phantom Stock (Supplemental Executive Retirement Plan) SERP | 2,854 footnote F2 | $11.43 footnote F3 | $33K | |
| ||||||
| Gregory T. Lucier - Director | Open-market purchase | Common Stock | 15,000 footnote F1 | $12.45 footnote F2 | $187K | |
| ||||||
| James D. Forbes - Director | Open-market purchase | Common Stock | 5,000 | $12.48 | $62K | |
| Aldo Mariano Roberto Denti - Officer | Grant or award | Stock Option (Right to Buy) | 270,200 | $0.00 | - | |
| Aldo Mariano Roberto Denti - Officer | Grant or award | Common Stock | 59,524 footnote F1 | $0.00 | - | |
| ||||||
Item 2.02, 9.01
Item 9.01
Item 5.02, 7.01, 9.01
Item 5.07
XRAY insider trading FAQ
What is the latest insider trade for XRAY?
DENTSPLY SIRONA Inc. (XRAY) had 3 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for XRAY runs to 124 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying XRAY stock?
No insider purchases of XRAY were filed in the last 90 days. 15 purchases are on record for this company.
How many insiders are selling XRAY stock?
No insider sales of XRAY were filed in the last 90 days.
Where can I see XRAY SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects XRAY Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jonathan Jay Mazelsky view on EDGAR
- - John C. Fortson view on EDGAR
- - Andrea L. Frohning view on EDGAR
- - Jonathan Jay Mazelsky view on EDGAR
- - Jonathan Jay Mazelsky view on EDGAR
- - Clyde Hosein view on EDGAR
- - Brian P. McKeon view on EDGAR
- - Brian T. Gladden view on EDGAR
- - Jonathan Jay Mazelsky view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where XRAY's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow XRAY with a 7-day demo
- XRAY on your watchlist
- Every XRAY Form 4 filing on record
- Up to 3 months of XRAY price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
